Recent advances in micro/nanomotors for antibacterial applications

• Published in: Journal of materials chemistry. B, Materials for biology and medicine Vol. 12; no. 21; pp. 5 - 523
• Main Authors: Wang, Wenxia, Luo, Hangyu, Wang, Han
• Format: Journal Article
• Language: English
• Published: England Royal Society of Chemistry 29.05.2024
• Subjects: Antibiotics; Antiinfectives and antibacterials; Antimicrobial activity; Antimicrobial agents; Bacteria; Bacterial diseases; Biofilms; Inactivation; Locomotion; Mass transfer; Micromanipulation; Micromixing; Micromotors; Microrobots; Multidrug resistance; Nanotechnology devices; Phagocytosis; Public health
• ISSN: 2050-750X; 2050-7518
• DOI: 10.1039/d3tb02718j

Currently, the rapid spread of multidrug-resistant bacteria derived from the indiscriminate use of traditional antibiotics poses a significant threat to public health worldwide. Moreover, established bacterial biofilms are extremely difficult to eradicate because of their high tolerance to traditional antimicrobial agents and extraordinary resistance to phagocytosis. Hence, it is of universal significance to develop novel robust and efficient antibacterial strategies to combat bacterial infections. Micro/nanomotors exhibit many intriguing properties, including enhanced mass transfer and micro-mixing resulting from their locomotion, intrinsic antimicrobial capabilities, active cargo delivery, and targeted treatment with precise micromanipulation, which facilitate the targeted delivery of antimicrobials to infected sites and their deep permeation into sites of bacterial biofilms for fast inactivation. Thus, the ideal antimicrobial activity of antibacterial micro/nanorobots makes them desirable alternatives to traditional antimicrobial treatments and has aroused extensive interest in recent years. In this review, recent advancements in antibacterial micro/nanomotors are briefly summarized, focusing on their synthetic methods, propulsion mechanism, and versatile antibacterial applications. Finally, some personal insights into the current challenges and possible future directions to translate proof-of-concept research to clinic application are proposed. Currently, the rapid spread of multidrug-resistant bacteria derived from the indiscriminate use of traditional antibiotics poses a significant threat to public health worldwide.